Skip to content
.

. Nuaman

Publications (3)

Stability Indicating Method Development and Validation of Cenobamate in Bulk and Dosage form by Liquid Chromatography

K. Athulya Damodharan, . Nuaman, M. Archana, Mariya Palathingal, P. Ashisha & Akash Marathakam · Journal of Pharmaceutical Research International · 2021

A simple, Precise, Accurate method was developed for the estimation of Cenobamate   by RP-HPLC technique. Chromatographic conditions used are stationary phase symmetry C18 (150 mm* 4.6 mm 5 µm), mobile phase Acetonitrile: 0.01NKH2PO4in the ratio of 55:45 and flow rate was maintai...

Open access Research Article 10.9734/jpri/2021/v33i46A32848

A Review on Antiviral Activity of Favipiravir

Mariya Palathingal, M. Archana, K. Athulya Damodharan, . Nuaman, P. Ashisha & Akash Marathakam · Journal of Pharmaceutical Research International · 2022

The emerging severe acute respiratory syndrome coronavirus 2 pandemic endangers patients and physicians all over the world. The potency of COVID-19 antiviral drugs is still a matter of debate. The growing understanding of COVID-19 virology and clinical manifestations is resulting...

Open access Research Article 10.9734/jpri/2022/v34i3B35387

Fedratinib: A Review of Its Pharmacology and Clinical Use

P. Ashisha, M. Archana, Mariya Palathingal, K. Athulya Damodharan, . Nuaman & Akash Marathakam · Journal of Pharmaceutical Research International · 2022

Fedratinib (INREBIC®) is a JAK2-selective inhibitor that has been developed as an oral treatment for myelofibrosis. It was approved for the first time in the United States in August 2019 to treat adult patients with intermediate-2 or high-risk primary or secondary (post-polycytha...

Open access Research Article 10.9734/jpri/2022/v34i38B36226